Of interest, gene deficiency or blockade of IL-18, OPN, or thrombin ameliorated the progression of RA and cancer, partly due to inhibiting angiogenesis (17–19, 24–26), although it has yet to be determined how these mediators contribute to pathologic angiogenesis. This evidence concerns the gene IL18 and cancer.